<p>Each point relates to a frequency bin in the 15.3–32.2 Hz range in individual muscles and subjects which showed significant coherence both before and after substance administration. The phase after the drug is plotted against the phase before. A, placebo, B, propranolol C, salbutamol. Dashed line indicates identity. Note that in (C) the majority of points lie below the line of identity.</p
<p>Signal showing changing morphology as a result of drug treatment. Field potential complex I and f...
<p>(a) Cyclical coherence between C<sub>z</sub> and tibialis anterior muscles of a participant with ...
<p>Obtained from Run0 and Run3 (Run2 is included for patient 07 only). Each panel represents a diffe...
<p>Top panel shows mean ± SEM coherence of all 23 subjects in the off (blue) and on (red) medication...
<p>Each column of this figure refers to the effects of a different substance: placebo (A,D,G,J), pro...
<p><b>a:</b> Area under the curve (AUC), a numerical integration, of the total firing fraction betwe...
<p>Both measures based on phase-synchronization show a similar behavior with an increase around seiz...
<p>A, finger acceleration power spectra, measured prior to salbutamol administration, averaged acros...
<p>The most left graphs (A,E,I) depict the coherence spectra within the 15–35 Hz frequency range for...
<p>The decrease in phase lag was plotted against the increase in LFP frequency. Stimulation was made...
<p>(A) alpha (8–12 Hz) band. (B) beta (13–30 Hz) band. (C) gamma (31–50 Hz) band. In each frequency ...
<p>(A) Coherence spectra during RS1 (black), after in-phase stimulation (RS3, green), and after anti...
<p>Power is represented as a big dot over each nucleus with different color intensity according to i...
<p>Average coherence spectra are shown for MG-EDB and TA-EDB in the lower limb (A,C) and for EDC-FDI...
<p>(A) Grand mean coherence average over four posterior channel pairs: The solid black line depicts ...
<p>Signal showing changing morphology as a result of drug treatment. Field potential complex I and f...
<p>(a) Cyclical coherence between C<sub>z</sub> and tibialis anterior muscles of a participant with ...
<p>Obtained from Run0 and Run3 (Run2 is included for patient 07 only). Each panel represents a diffe...
<p>Top panel shows mean ± SEM coherence of all 23 subjects in the off (blue) and on (red) medication...
<p>Each column of this figure refers to the effects of a different substance: placebo (A,D,G,J), pro...
<p><b>a:</b> Area under the curve (AUC), a numerical integration, of the total firing fraction betwe...
<p>Both measures based on phase-synchronization show a similar behavior with an increase around seiz...
<p>A, finger acceleration power spectra, measured prior to salbutamol administration, averaged acros...
<p>The most left graphs (A,E,I) depict the coherence spectra within the 15–35 Hz frequency range for...
<p>The decrease in phase lag was plotted against the increase in LFP frequency. Stimulation was made...
<p>(A) alpha (8–12 Hz) band. (B) beta (13–30 Hz) band. (C) gamma (31–50 Hz) band. In each frequency ...
<p>(A) Coherence spectra during RS1 (black), after in-phase stimulation (RS3, green), and after anti...
<p>Power is represented as a big dot over each nucleus with different color intensity according to i...
<p>Average coherence spectra are shown for MG-EDB and TA-EDB in the lower limb (A,C) and for EDC-FDI...
<p>(A) Grand mean coherence average over four posterior channel pairs: The solid black line depicts ...
<p>Signal showing changing morphology as a result of drug treatment. Field potential complex I and f...
<p>(a) Cyclical coherence between C<sub>z</sub> and tibialis anterior muscles of a participant with ...
<p>Obtained from Run0 and Run3 (Run2 is included for patient 07 only). Each panel represents a diffe...